Burney CO Supernus Pharmaceuticals, Inc. Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Burney CO holds 11,821 shares of SUPN stock, worth $420,709. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,821

Previous 14,853 20.41%

Holding current value

$420,709

Previous $397,000 7.3%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$25.77 - $35.16 $78,134 - $106,605	-3,032 Reduced 20.41%	11,821 $368,000
Q2 2024 Jul 29, 2024	SELL	$25.99 - $33.85 $165,452 - $215,489	-6,366 Reduced 30.0%	14,853 $397,000
Q1 2024 May 22, 2024	SELL	$27.11 - $35.17 $10,383 - $13,470	-383 Reduced 1.77%	21,219 $723,000
Q4 2023 Feb 12, 2024	SELL	$22.72 - $29.68 $1.14 Million - $1.49 Million	-50,109 Reduced 69.88%	21,602 $625,000
Q3 2023 Nov 08, 2023	SELL	$27.57 - $32.91 $3.16 Million - $3.77 Million	-114,648 Reduced 61.52%	71,711 $1.98 Million
Q2 2023 Aug 09, 2023	BUY	$29.91 - $38.73 $3.69 Million - $4.78 Million	123,487 Added 196.41%	186,359 $5.6 Million
Q1 2023 May 10, 2023	BUY	$34.93 - $42.03 $12,470 - $15,004	357 Added 0.57%	62,872 $2.28 Million
Q4 2022 Feb 06, 2023	BUY	$31.09 - $37.88 $1.14 Million - $1.39 Million	36,673 Added 141.91%	62,515 $2.23 Million
Q3 2022 Nov 15, 2022	SELL	$28.79 - $35.41 $369,231 - $454,133	-12,825 Reduced 33.17%	25,842 $875,000
Q2 2022 Aug 12, 2022	SELL	$25.33 - $34.25 $823,022 - $1.11 Million	-32,492 Reduced 45.66%	38,667 $1.12 Million
Q1 2022 May 09, 2022	SELL	$28.51 - $32.9 $52,600 - $60,700	-1,845 Reduced 2.53%	71,159 $2.3 Million
Q4 2021 Feb 11, 2022	SELL	$26.37 - $34.22 $155,873 - $202,274	-5,911 Reduced 7.49%	73,004 $2.13 Million
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $109,578 - $146,120	-4,655 Reduced 5.57%	78,915 $2.11 Million
Q2 2021 Aug 06, 2021	SELL	$26.72 - $33.19 $23,887 - $29,671	-894 Reduced 1.06%	83,570 $2.57 Million
Q1 2021 May 13, 2021	SELL	$24.15 - $31.45 $435,617 - $567,295	-18,038 Reduced 17.6%	84,464 $2.21 Million
Q4 2020 Feb 11, 2021	SELL	$17.7 - $25.81 $2.02 Million - $2.95 Million	-114,211 Reduced 52.7%	102,502 $2.58 Million
Q3 2020 Dec 14, 2020	BUY	$20.2 - $25.05 $1.02 Million - $1.27 Million	50,736 Added 30.57%	216,713 $4.52 Million
Q2 2020 Aug 13, 2020	BUY	$17.09 - $24.89 $2.84 Million - $4.13 Million	165,977 New	165,977 $3.94 Million

Others Institutions Holding SUPN

# of Institutions

281

Shares Held

60.6M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account